Impact of PET/CT diagnosis on patient management: prospective register study of the Department of Radiology of the University Tübingen

Impact of PET/CT diagnosis on patient management: prospective register study of the Department of Radiology of the University Tübingen - PET/CT R1

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00014326

Enrollment

7400

Registered

2018-03-23

Start date

2013-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C97

Interventions

Group 1: Patients with cancer or suspicion about cancer, having a PET/CT examination due to clinical indication at the Department of Radiology (University of Tübingen). When a PET/CT scan was ordered

Eligibility

Sex/Gender

All

Age

No minimum to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with cancer or suspicion about cancer, having a PET/CT examination due to clinical indication at the Department of Radiology (University of Tübingen), start: 01. March 2013 - no minimum age - informed consent of patient or custodian

Exclusion criteria

Exclusion criteria: - no signed informed consent of patient or custodian - patients receiving a PET/CT-examination within the scope of an interventional clinical trial (drug)

Design outcomes

Primary

Measure	Time frame
Prospective data collection (start: 01. March 2013) of oncologic patients undergoing clinical indicated PET/CT examination.	—

Secondary

Measure	Time frame
Evaluation of the clinical impact of PET/CT diagnosis on further therapeutical/diagnostic strategy (patient's management): A change in management after PET/CT was assigned to the following different categories: (1) a switch from nontreatment to active treatment or vice versa, (2) in case of treatment, change of therapeutic goal from curative to palliative or vice versa, (3) in case of nontreatment, a change to watchful waiting including best supportive care, or (4) the prevention of invasive tests. Improvement of PET/CT quality.	—

Measure

Time frame

Evaluation of the clinical impact of PET/CT diagnosis on further therapeutical/diagnostic strategy (patient's management): A change in management after PET/CT was assigned to the following different categories: (1) a switch from nontreatment to active treatment or vice versa, (2) in case of treatment, change of therapeutic goal from curative to palliative or vice versa, (3) in case of nontreatment, a change to watchful waiting including best supportive care, or (4) the prevention of invasive tests. Improvement of PET/CT quality.

—

Countries

Germany

Contacts

Public ContactChristina Pfannenberg

Universitätsklinikum Tübingen, Radiologische Klinik, Diagnostische & Interventionelle Radiologie

christina.pfannenberg@med.uni-tuebingen.de07071-29 82756

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026